Pharmaceutical lifecycle management : (Record no. 14372)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01730nam a2200241Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | NULRC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250520102739.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250520s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780470487532 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | NULRC |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | HD 9666.5 .E45 2012 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ellery, Tony |
| Relator term | author |
| 245 #0 - TITLE STATEMENT | |
| Title | Pharmaceutical lifecycle management : |
| Remainder of title | making the most of each and every brand / |
| Statement of responsibility, etc. | Tony Ellery and Neal Hansen |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Hoboken, New Jersey : |
| Name of publisher, distributor, etc. | John Wiley & Son, Inc., |
| Date of publication, distribution, etc. | c2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xxii, 389 pages : |
| Other physical details | illustrations ; |
| Dimensions | 24 cm. |
| 365 ## - TRADE PRICE | |
| Price amount | USD63.53 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | pt. A. Lifecycle management business environment -- pt. B. Lifecycle management regulatory and legal environment -- pt. C. Patents and exclusivities -- pt. D. Developmental LCM -- pt. E. Commercial LCM -- pt. F. Biologics and biosimilars -- pt. G. The integrated brand LCM strategy and its implementation -- pt. H. Integrating LCM with portfolio management. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to maximize the value of their products. Demonstrating how different measures can be combined to create winning strategies, Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand explores this increasingly important field to help readers understand what they can--and must--do to get. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | DRUG APPROVAL -- ECONOMIC ASPECTS |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hansen, Neal |
| Relator term | co-author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | Books |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Cost, normal purchase price | Total checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Pharmacy | LRC - Main | National University - Manila | General Circulation | 08/26/2016 | Purchased - Amazon | 63.53 | GC HD 9666.5 .E45 2012 | NULIB000012131 | 05/20/2025 | c.1 | 05/20/2025 | Books |